MedTrace Pharma: Funding, Investors & Team (Sep 2026)
MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner. By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at the same time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.
MedTrace Pharma has raised $48.2M across 2 funding rounds on record, the most recent an undisclosed round of $19.0M announced in Sep 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MedTrace Pharma Company Profile and Key Stats
Latest funding round on record: Sep 2023.
MedTrace Pharma Funding Rounds
MedTrace Pharma raised $29.2M in an undisclosed round announced in May 2021.
2.3 years later, an undisclosed round of $19.0M was announced in Sep 2023.
MedTrace Pharma Founders and Leadership Team
Contact details for the MedTrace Pharma team: 1 of 1 has an email address on file.
Start 14-day free trial →MedTrace Pharma Funding Compared to Other Biotechnology Startups
MedTrace Pharma's latest round of $19.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MedTrace Pharma in Biotechnology and Lyngby
Companies Similar to MedTrace Pharma
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Alcolase is a Danish life science start-up that specializes in alcohol flushing.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…
Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…
Pioneering new sustainable bio-based ingredients
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…
EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…
MedTrace Pharma Funding FAQs
What does MedTrace Pharma do?
MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner. By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at the same time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.
How much funding has MedTrace Pharma raised?
MedTrace Pharma has raised $48.2M across 2 rounds on record. The most recent is an undisclosed round of $19.0M announced in Sep 2023.
When did MedTrace Pharma last raise funding?
MedTrace Pharma's most recent funding round on record is an undisclosed round of $19.0M, announced in Sep 2023.
Who is the CEO of MedTrace Pharma?
Martin Stenfeldt is listed as CEO at MedTrace Pharma.
Where is MedTrace Pharma headquartered?
MedTrace Pharma is based in Lyngby, Hovedstaden, Denmark.
How many employees does MedTrace Pharma have?
MedTrace Pharma is in the 11-50 employee band.
How does MedTrace Pharma's funding compare to other Biotechnology startups?
MedTrace Pharma's latest round of $19.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's MedTrace Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MedTrace Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.